Intercept Pharmaceuticals Logo

Intercept Pharmaceuticals

Biopharmaceutical company

Non-viral Liver Diseases
Rare Diseases
Biotechnology
Innovation

About Intercept Pharmaceuticals

Intercept Pharmaceuticals, a subsidiary of Alfasigma S.p.A., focuses on developing and commercializing novel therapeutics for rare liver diseases like primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). Our New Jersey-based team is dedicated to improving patients' lives and addressing the liver community's most pressing needs. Join us in this vital mission.

Overview

  • Website
  • LinkedIn
  • 201-500 employees
  • Founded in 2002
  • No active jobs

Benefits of using Remote First Jobs

Discover Hidden Jobs

Unique jobs you won't find on other job boards.

Advanced Filters

Filter by category, benefits, seniority, and more.

Priority Job Alerts

Get timely alerts for new job openings every day.

Manage Your Job Hunt

Save jobs you like and keep a simple list of your applications.

Search remote, work from home, 100% online jobs

We help you connect with top remote-first companies.

Search jobs

Hiring remote talent? Post a job